Corrigendum to “Seroprevalence and durability of rubella virus antibodies in a highly immunized population”. [Vaccine 37 (2019) 3876–3882] (Vaccine (2019) 37(29) (3876–3882), (S0264410X19306735), (10.1016/j.vaccine.2019.05.049))

Stephen N. Crooke, Iana H. Haralambieva, Diane E. Grill, Inna G. Ovsyannikova, Richard B. Kennedy, Gregory A. Poland

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the previously published Acknowledgements were incomplete. They are reproduced in full below: AcknowledgmentsWe would like to thank the staff of the Mayo Clinic Vaccine Research Group and all of the participants in this study. We would also like to thank Emily A. Voigt for the assessment of rubella antibody titers and the initial analysis identifying low and high responders to rubella. We thank Caroline L. Vitse for editorial assistance with the preparation of this manuscript. The work reported was funded by the National Institutes of Health under Award Number R37AI048793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Mayo Clinic Biobank was supported by funding from the Mayo Clinic Center for Individualized Medicine. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)6858
Number of pages1
JournalVaccine
Volume38
Issue number43
DOIs
StatePublished - Oct 7 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Corrigendum to “Seroprevalence and durability of rubella virus antibodies in a highly immunized population”. [Vaccine 37 (2019) 3876–3882] (Vaccine (2019) 37(29) (3876–3882), (S0264410X19306735), (10.1016/j.vaccine.2019.05.049))'. Together they form a unique fingerprint.

Cite this